Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
200–300 mg daily for adults; 100–200 mg/day for children
30–60 minutes before breakfast, Between meals on an empty stomach
Bovine lactoferrin capsule or powder (≥95% purity)
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
4–8 weeks of use
4–8 weeks
4–8 weeks
6–12 weeks
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Effect of Lactoferrin Supplementation on Inflammation, Immune Function, and Prevention of Respiratory Tract Infections in Humans: A Systematic Review and Meta-analysis.
Advances in Nutrition (2022) · Meta analysis
Lactoferrin significantly reduced IL-6 in adults (mean difference: -24.9 pg/mL; 95% CI: -41.64, -8.08 pg/mL)
Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials.
Clinical Nutrition ESPEN (2021) · Meta analysis
Pooled analysis of RCTs showed significant reduction in respiratory tract infection risk with lactoferrin supplementation
Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials.
Nutrients (2022) · Meta analysis
Lactoferrin was non-inferior to ferrous sulfate for increasing hemoglobin and serum ferritin
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Based on multiple meta-analyses showing OR 0.78 for RTI reduction. Effect more pronounced in children and preterm infants. Conservative estimates due to heterogeneity in populations studied.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 6.3/10) and wins in 3 of 3 categories.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 78).
No known interactions between Lactoferrin and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.